Oppenheimer Asset Management Inc. lessened its position in  Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 31.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,744 shares of the financial services provider’s stock after selling 2,214 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Trupanion were worth $263,000 at the end of the most recent reporting period. 
A number of other large investors have also added to or reduced their stakes in TRUP. AlphaQuest LLC grew its holdings in Trupanion by 940.6% in the 1st quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 950 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Trupanion by 11.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 235 shares during the last quarter. GAMMA Investing LLC grew its holdings in Trupanion by 30.1% in the 2nd quarter. GAMMA Investing LLC now owns 2,133 shares of the financial services provider’s stock worth $118,000 after acquiring an additional 494 shares during the last quarter. Lake Hills Wealth Management LLC bought a new stake in Trupanion in the 2nd quarter worth $204,000. Finally, Mutual of America Capital Management LLC bought a new stake in Trupanion in the 2nd quarter worth $240,000.
Insider Activity
In other news, Director Darryl Rawlings sold 30,369 shares of Trupanion stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $44.70, for a total transaction of $1,357,494.30. Following the completion of the transaction, the director directly owned 1,413,281 shares in the company, valued at approximately $63,173,660.70. This trade represents a 2.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 2,800 shares of Trupanion stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the transaction, the chief financial officer owned 6,451 shares of the company’s stock, valued at $293,907.56. The trade was a 30.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 70,645 shares of company stock worth $3,128,119. Insiders own 5.42% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Analysis on TRUP
Trupanion Trading Down 1.2%
Shares of TRUP opened at $39.99 on Monday. The firm’s 50-day moving average price is $43.61 and its 200-day moving average price is $46.30. The firm has a market capitalization of $1.72 billion, a price-to-earnings ratio of 153.81 and a beta of 1.83. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. Trupanion, Inc. has a 1-year low of $31.00 and a 1-year high of $57.90.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The firm had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. During the same quarter in the previous year, the firm posted ($0.14) EPS. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
 - How to Use Stock Screeners to Find Stocks
 - Is Lemonade Stock Set for a Big Squeeze After Earnings?
 - Why Invest in High-Yield Dividend Stocks?
 - Caterpillar Stock Could Top $650 by Year’s End
 - Which Wall Street Analysts are the Most Accurate?
 - ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
 
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
